@ARTICLE{
author={McCrimmon Rory J,Al Sifri Saud,Emral Rifat,Mohan Viswanathan,Sauque-Reyna Leobardo,Trescoli Carlos,Lalic Nebojsa M,Alvarez Agustina,Demil Nacima,Coudert Mathieu,Shaunik Alka,Bonnemaire Mireille,Rosenstock Julio},
year={2021},
title={Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin-treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial},
journal={DIABETES OBESITY & METABOLISM},
volume={23},
number={6},
pages={1221-1231},
document_type={Article},
}